Oscar Health, Inc. (OSCR)
Oscar Health: Investor Day Offered New TAM Forecast Which Is Very Bullish, If Smoothly Executed
Oscar Health is upgraded to Strong Buy with a new $45 fair value, reflecting raised 2026–2029 earnings targets and an expanded TAM. Management projects 2029 EPS of $4+ and 2026 operating earnings of $600–800M, driven by ACA execution, CHOICE, and Lucie marketplace growth. CHOICE and Lucie expand OSCR's addressable market by 65%, with revenue estimates rising from $18.85B in 2026 to $32.6B in 2029.
Despite Fast-paced Momentum, Oscar Health (OSCR) Is Still a Bargain Stock
Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Oscar Health, Inc. (OSCR) Analyst/Investor Day Transcript
Oscar Health, Inc. (OSCR) Analyst/Investor Day Transcript
Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader Market
Oscar Health, Inc. (OSCR) closed at $32.62 in the latest trading session, marking a -3.53% move from the prior day.
Best Growth Stocks to Buy for September 15th
VLO, SNDR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 15th, 2026.
Is Oscar Health (OSCR) Outperforming Other Finance Stocks This Year?
Here is how Oscar Health, Inc. (OSCR) and Amerant Bancorp Inc. (AMTB) have performed compared to their sector so far this year.
Oscar Health, Inc. (OSCR) Just Overtook the 20-Day Moving Average
After reaching an important support level, Oscar Health, Inc. (OSCR) could be a good stock pick from a technical perspective. OSCR surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
Oscar Health, Inc. (OSCR) Just Overtook the 50-Day Moving Average
Oscar Health, Inc. (OSCR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, OSCR broke out above the 50-day moving average, suggesting a short-term bullish trend.
Oscar Health Membership Surges but Profitability Remains Key
Oscar Health's membership jumps 46% to 2.96 million, but seasonal enrollment and medical utilization keep profitability in focus.
Oscar Health Skyrockets 109% YTD: Time to Bet on the Stock Now?
Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its price-to-book multiple tops the industry average.
Fast-paced Momentum Stock Oscar Health (OSCR) Is Still Trading at a Bargain
Oscar Health (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Oscar Health Q2 Earnings Call Highlights
Oscar Health NYSE: OSCR reported record profitability for the first half of 2026 and raised its full-year operating outlook, citing membership growth, disciplined pricing, favorable utilization trends and lower administrative expense ratios.
